207600-27-9

Upstream product

• 530-62-1 1,1'-carbonyldiimidazole 
• 207600-26-8 (R)-1-[(4S,5S)-5-((R)-1-Amino-2-p-tolyl-ethyl)-2,2-dimethyl-[1,3]dioxolan-4-yl]-2-p-tolyl-ethylamine 
• 207600-25-7 N'-(1-{5-[1-(N',N'-dimethyl-hydrazino)-2-p-tolyl-ethyl]-2,2-dimethyl-[1,3]dioxolan-4-yl}-2-p-tolyl-ethyl)-N,N-dimethyl-hydrazine 

Downstream Products

• 249613-02-3 C₄₀H₃₈F₂N₄O₃ 
• 548795-09-1 (3aS,4R,8R,8aS)-5-Butyl-2,2-dimethyl-4,8-bis-(4-methyl-benzyl)-hexahydro-1,3-dioxa-5,7-diaza-azulen-6-one 
• 207600-28-0 (3aS,4R,8R,8aS)-5-Benzyl-2,2-dimethyl-4,8-bis-(4-methyl-benzyl)-hexahydro-1,3-dioxa-5,7-diaza-azulen-6-one 
• 548795-16-0 5-[(3aS,4R,8R,8aS)-7-Butyl-2,2-dimethyl-4,8-bis-(4-methyl-benzyl)-6-oxo-hexahydro-1,3-dioxa-5,7-diaza-azulen-5-ylmethyl]-2-fluoro-benzonitrile 
• 207600-29-1 5-[(3aS,4R,8R,8aS)-7-Benzyl-2,2-dimethyl-4,8-bis-(4-methyl-benzyl)-6-oxo-hexahydro-1,3-dioxa-5,7-diaza-azulen-5-ylmethyl]-2-fluoro-benzonitrile 
• 548795-26-2 (3aS,4R,8R,8aS)-5-(3-Amino-1H-indazol-5-ylmethyl)-7-butyl-2,2-dimethyl-4,8-bis-(4-methyl-benzyl)-hexahydro-1,3-dioxa-5,7-diaza-azulen-6-one 
• 207600-30-4 (3aS,4R,8R,8aS)-5-(3-Amino-1H-indazol-5-ylmethyl)-7-benzyl-2,2-dimethyl-4,8-bis-(4-methyl-benzyl)-hexahydro-1,3-dioxa-5,7-diaza-azulen-6-one 

Relevant academic research and scientific papers

Synthesis, antiviral activity and pharmacokinetics of P1/P1′ substituted 3-aminoindazole cyclic urea HIV protease inhibitors

A series of P1/P1′ substituted cyclic urea analogues were prepared in an attempt to increase the intra-cellular antiviral potency of the nonsymmetrical 3-aminoindazoles DMP 850 and DMP 851. The effect of alkyl substitution of the P1/P1′ residues on cellul